1. Home
  2. VSME vs ARTL Comparison

VSME vs ARTL Comparison

Compare VSME & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSME
  • ARTL
  • Stock Information
  • Founded
  • VSME 2013
  • ARTL 2011
  • Country
  • VSME Hong Kong
  • ARTL United States
  • Employees
  • VSME N/A
  • ARTL N/A
  • Industry
  • VSME
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • VSME
  • ARTL Health Care
  • Exchange
  • VSME Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • VSME 4.2M
  • ARTL 3.7M
  • IPO Year
  • VSME 2023
  • ARTL N/A
  • Fundamental
  • Price
  • VSME $1.20
  • ARTL $1.21
  • Analyst Decision
  • VSME
  • ARTL Strong Buy
  • Analyst Count
  • VSME 0
  • ARTL 2
  • Target Price
  • VSME N/A
  • ARTL $5.50
  • AVG Volume (30 Days)
  • VSME 683.7K
  • ARTL 28.9K
  • Earning Date
  • VSME 12-23-2024
  • ARTL 11-12-2024
  • Dividend Yield
  • VSME N/A
  • ARTL N/A
  • EPS Growth
  • VSME N/A
  • ARTL N/A
  • EPS
  • VSME N/A
  • ARTL N/A
  • Revenue
  • VSME $8,488,339.00
  • ARTL N/A
  • Revenue This Year
  • VSME N/A
  • ARTL N/A
  • Revenue Next Year
  • VSME N/A
  • ARTL N/A
  • P/E Ratio
  • VSME N/A
  • ARTL N/A
  • Revenue Growth
  • VSME 3.15
  • ARTL N/A
  • 52 Week Low
  • VSME $0.65
  • ARTL $0.91
  • 52 Week High
  • VSME $6.16
  • ARTL $1.75
  • Technical
  • Relative Strength Index (RSI)
  • VSME 51.19
  • ARTL 64.07
  • Support Level
  • VSME $1.04
  • ARTL $1.09
  • Resistance Level
  • VSME $1.20
  • ARTL $1.19
  • Average True Range (ATR)
  • VSME 0.23
  • ARTL 0.06
  • MACD
  • VSME -0.01
  • ARTL 0.01
  • Stochastic Oscillator
  • VSME 21.05
  • ARTL 100.00

About VSME VS Media Holdings Limited

VS Media Holdings Ltd manages a global network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fanbases on social media platforms. The company's business provides value to two major business stakeholders: Creators and Brands. Its Value to Creators: It empowers and supports Creators by providing them with production facilities, training, and funding to produce quality content. Its Value to Brands: the company bridges the divide between Brands and Creators by helping Brands reach their target audience effectively by advising on content strategy and budget and recommending specific Creators.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing, and commercializing treatments that control endocannabinoid systems. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.

Share on Social Networks: